|December 11, 2017
Sanofi Genzyme: Arthritis Medication Should Not Be Used Due To Side Effects
[from AMA Morning Rounds]
Eighteen thousand gel-filled syringes of Synvisc-One, used to treat knee arthritis, from a single batch, have been linked to "an unexpected increase in the number of labelled adverse events."
The halt applies only to a single lot of Synvisc-One that bears the identification number 7RSL021, according to Heather Guzzi, a spokeswoman for the parent company in Bridgewater, N.J.< Previous Article | Next Article >
[ return to top ]
ensure delivery of Maine Medicine Weekly Update,
please add 'firstname.lastname@example.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm
For more information or to contact us directly, please visit www.mainemed.com | ©